← Back to guidelines
Pediatrics11 papers

Vertical overbite

Last edited: 4/15/2026

Overview

Congenital vertical talus (CVT) is a rare congenital foot deformity characterized by a rocker-bottom appearance due to a complete dislocation of the talonavicular joint and supination of the foot. 1

Diagnosis

  • Clinical examination revealing a rocker-bottom foot shape and limited dorsiflexion.
  • Radiographic confirmation showing characteristic joint dislocations and alignment issues.
  • Differentiation between idiopathic and syndromic cases may require additional clinical and genetic assessments. 1
  • Management

  • First-line Treatment: Minimally invasive approach (Dobbs method/reverse Ponseti technique) involving soft tissue manipulation and serial casting.
  • Timing: Early intervention, typically commencing treatment around 6 months of age.
  • Follow-up: Long-term follow-up necessary to assess outcomes, with mean follow-up periods often exceeding 6 years. 1
  • Special Populations

  • Pediatrics: Early intervention is crucial for optimal outcomes in pediatric patients with CVT. 1
  • Comorbid Syndromes: Treatment outcomes may vary between idiopathic and syndromic cases, requiring tailored approaches. 1
  • Key Recommendations

  • Initiate minimally invasive treatment (Dobbs method/reverse Ponseti technique) for congenital vertical talus early, ideally around 6 months of age, to achieve better outcomes. (Evidence: Moderate) 1
  • Conduct long-term follow-up evaluations, typically over 6 years, to monitor the effectiveness and durability of the treatment. (Evidence: Moderate) 1
  • Consider individualized treatment strategies based on whether the CVT is idiopathic or associated with a syndromic condition, given potential differences in outcomes. (Evidence: Weak) 1
  • References

    1 Hafez M, Davis N. Outcomes of a Minimally Invasive Approach for Congenital Vertical Talus With a Comparison Between the Idiopathic and Syndromic Feet. Journal of pediatric orthopedics 2021. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG